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Abstract   
The literature suggests that women of different races are more or less likely to use certain contraceptive 
methods and patient race can influence which contraceptive recommendations a provider makes.   To explore 
whether health care providers treat individuals of different races differently, we conducted a preliminary 
investigation on whether medical students recommended different contraceptive methods for hypothetical patients 
presenting with the same clinical features who only varied by race.  Third- and fourth-year medical students (n=103) 
at the University of Hawai‘i completed an online survey. Students read case studies about a 23-year-old and 36-
year-old patient and then made contraceptive recommendations. All students reviewed the same scenarios, with the 
exception of the patient’s name which was randomly assigned to represent one of five racial/ethnic groups (White, 
Chinese, Filipina, Native Hawaiian, and Micronesian). Recommendations were analyzed using χ2 tests and bivariate 
logistic regressions. For the younger patient, students were most likely to recommend intrauterine devices (IUDs), 
followed by the contraceptive pill and Etonogestrel implant; recommendations did not differ by race/ethnicity (P = 
.91). For the older patient, students were most likely to recommend IUDs or sterilization, and Micronesian women 
were more likely to receive sterilization recommendations compared to White women (60% versus 27%, P = .04).  
In summary, contraceptive recommendations, specifically the frequency of recommending sterilization varied by 
race. Our findings add to the literature exploring the role of a patient’s race/ethnicity on recommendations for 
contraception and highlights the need for more studies exploring the etiology of health care disparities.  
  
 
Keywords: contraception, disparities, race/ethnicity, medical students, sterilization 
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Introduction 
 Despite national initiatives by organizations like the Department of Health and Human Services and the 
Centers for Disease Control and Prevention to provide equitable health care, race/ethnicity and socioeconomic status 
disparities in health outcomes persist.1-3 These disparities reflect not only systematic differences in access to high-
quality care, but also the attitudes and behavior demonstrated by healthcare providers toward patients from socially 
disadvantaged groups.4-7 For example, race and socioeconomic status can influence a woman’s contraception use 
and providers’ recommendations of contraceptive methods.8-10 Studies have demonstrated that healthcare providers 
may be more likely to recommend intrauterine devices (IUDs) to Blacks, Latinas and low socioeconomic status 
Whites as compared to high socioeconomic status White women.8  
Low access to quality healthcare can lead to an increase in unintended pregnancy, particularly among 
women of color. Although approximately half of all pregnancies in the United States are unintended, Black women 
have a rate of unintended pregnancy of 79 per 1,000 women age 15 to 44 and Hispanic women have a rate of 58 per 
1,000, both are significantly higher than the rate among non-Hispanic White women (33 per 1,000).11 While the 
endorsement of methods like IUDs, which are long-acting and highly-effective, could reflect an effort to reduce 
unintended pregnancy among communities that are disparately experiencing unintended pregnancies, it could also 
be perceived as a method of fertility control.8, 10 Women using IUDs and implants must see a health care provider to 
remove them and regain fertility. 
  In addition to encouraging the use of highly effective but reversible contraceptive methods, health care 
providers also perform tubal sterilizations more commonly in minority women (Black and Hispanic), and women 
with low-income, public insurance, and less education.12, 13 This higher tubal sterilization rate may be attributable to 
cultural preferences among patients, insurance status, and 
/or racial/ethnic discrimination from providers.12-15 Highlighting the potential role of provider biases in tubal 
sterilization, low income racial/ethnic minority women are more likely to be advised to limit their childbearing than 
middle-class White women, and racial minority women have reported that sterilization prevented them from 
conceiving more wanted children.16-18  
The majority of research examining how patient demographics may influence contraceptive 
recommendations has been conducted in the continental United States (US), where Whites make up 77% of the 
population.19 Little is known of whether biased recommendations will emerge in contexts where Whites are not the 
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numerical majority, an important consideration given the growing diversity occurring within the US. By 2044, more 
than half of all individuals living in the US are projected to belong to a racial/ethnic minority group.20 Within the 
US, Hawaiʻi provides a unique setting to examine questions related to racial diversity and majority group status as it 
reflects the nation’s anticipated population diversity. In 2015, 73% of individuals living in Hawaiʻi identified as a 
racial minority, with only 27% identifying as mono-racial White.19 Hawaiʻi also has the nation’s largest population 
of Native Hawaiians and Pacific Islanders in the US, comprising 26% of the population, allowing researchers to 
examine whether known disparities in contraceptive recommendations for Black and Hispanic women extend to 
women from other disadvantaged racial/ethnic minority groups.21 We sought to explore whether potential race-
related biases in providers’ contraceptive recommendations are present early in one’s medical career, during medical 
school. We conducted a study of medical students’ contraceptive recommendations using standardized case studies 
that varied only race of the patient to see if this variation affected their recommendations.  
 
Methods 
Case Studies 
 We presented 10 case studies with standardized descriptions of a female patient requesting a method of 
birth control (see Table 1). Patients in the case studies varied systematically by age (either 23- or 36-years-old), and 
race/ethnicity, specifically White, Chinese, Filipina, Native Hawaiian, and Micronesian. These are a few of the 
major racial/ethnic groups in Hawaiʻi and research has demonstrated differences in health-related outcomes between 
these groups.22 The race/ethnicity of the patients was portrayed through the use of prototypical names (Table 2). The 
names of the White, Chinese, and Hawaiian patients were pre-tested with a sample of 18 undergraduate students 
from the University of Hawaiʻi who demonstrated, on average, 90% agreement that these names represented women 
from the targeted racial groups. The Filipina and Micronesian names were identified as prototypical based on the 
researchers’ experiences with these population groups in their clinical practice and consultation with leaders in the 
Filipino and Micronesian medical community.  
Study Design 
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 We emailed surveys to 195 third and fourth year medical students who had completed all required didactic 
education in obstetrics and gynecology from the John A. Burns School of Medicine at the University of Hawaiʻi 
between June 2014 and July 2015. Students were emailed a link to an online survey and sent a reminder follow-up 
email two weeks later. Participants were first presented with case studies and asked to identify which contraceptive 
method they would recommend from a list of six options (female sterilization [laparoscopic tubal sterilization or 
hysteroscopic sterilization], intrauterine device [copper or Levonorgestrel IUD], Etonogestrel implant [Nexplanon], 
depot medroxyprogesterone acetate [DMPA3-month injection], oral contraceptive pills, or condoms). Methods were 
always presented in this order and students were restricted to selecting only one option. For scoring purposes, 
contraception methods were reverse coded into ranked data such that responses ranged from least (1 – condoms) to 
most (6- female sterilization) effective methods. Each participant answered questions about two case studies: one a 
23-year-old woman and the other a 36-year-old woman. The race of the patients in the case studies was not 
explicitly disclosed, but the names were changed systematically to reflect White, Chinese, Filipina, Hawaiian, or 
Micronesian race. For each participant, the selected names for the 23-year old and 36-year old reflected the same 
race. The order of the case studies was counterbalanced between participants so that an equal number of students 
read the scenario about the 23-year old woman versus the 36-year old woman first. The authors created an item to 
gauge participants’ level of experience with contraception in clinical settings (responses included None, Not Very 
Much, A Little, Some, Very Much, and Substantial). Finally, participants completed a demographic questionnaire 
which included their racial self-identification. 
This study was approved by the Committee on Human Studies at the University of Hawaiʻi. All participants 
provided informed consent before completing the study. To minimize social desirability bias, several questions that 
did not directly relate to the study objective were included in the survey to blind participants to the primary study 
objective and the study intent was not revealed to participants until they completed the survey. Students received a 
$5 gift card for their participation. 
Statistical Analyses 
 Our primary outcome was to describe whether participants’ contraceptive recommendations differed by 
patient race in the case studies. We used a convenience sample of all available third and fourth year medical students 
at our institution. We used a series of χ2 tests, Spearman correlations and pre-specified bivariate logistic regressions 
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to analyze whether contraceptive recommendations differed by patient race, participants’ clinical experience or 
participants’ race. All analyses were performed with SPSS Version 22 (IBM Corp: Armonk, NY). 
 
Results 
One hundred and twenty-four students enrolled in the study and consented to participate, of which 103 unique 
individuals completed the case studies and provided contraceptive recommendations. Of these 103, four students did 
not provide their experience with contraception in a clinical setting and eight students did not provide their racial 
identification. The number of case studies for each race/ethnicity group was balanced (χ2(4) = .54, P = .97); 22 
participants read case studies about White patients, 21 about Chinese patients, 22 about Filipina patients, 18 about 
Hawaiian patients, and 20 about Micronesian patients. Post hoc analysis using G*Power software version 3.1.9.2 
(Heinrich-Heine-Universität Düsseldorf: Kiel, Germany) for χ2 goodness-of-fit tests indicated that 103 students 
provided 68% power to detect a medium effect when comparing recommendations between five racial/ethnic groups 
using a binary outcome of recommending sterilization.  
 
Recommendations for Contraception  
 For the 23-year-old patient, a difference in the frequency of contraceptive recommendations was noted 
(χ2(4) = 59.86, P < .001, Figure 1). Students were most likely to recommend IUDs, followed by the contraceptive 
pill and Etonogestrel implant. Condoms and depot medroxyprogesterone acetate were less likely to be 
recommended. No recommendations were made for female sterilization in the younger patient case study. 
Contraceptive recommendations did not differ by race of the patient presented in the case studies for the younger 
scenario (χ2(16) = .901, P = .91). 
A difference in the frequency of contraceptive recommendations for the 36-year-old patient was noted 
(χ2(5) = 118.65, P < .001, see Figure 2). Recommendations for the older women most frequently included IUD and 
female sterilization, followed by the contraceptive pill and Etonogestrel implant. As with the younger patient, 
recommendations for condoms and depot medroxyprogesterone acetate occurred less frequently. We did not note a 
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difference in contraceptive recommendations when examining all 5 methods separately (i.e. condoms, pills, DMPA, 
implants, IUDs, and sterilization) for the 36-year-old patient ( χ2(20) = 17.39, P = .63).   
Recommendations for Sterilization 
To further examine our a priori assumption that the frequency of sterilization recommendations would 
differ across patient race, we coded contraceptive recommendations into non-sterilization (IUD, Etonogestrel 
implant, depot medroxyprogesterone acetate, contraceptive pills, and condoms and sterilization (female sterilization) 
categories. Because the 23-year-old patient did not receive recommendations for sterilization, we focused on 
recommendations made for the 36-year-old patient. Previous research has demonstrated that women of color 
experience disparities in contraception recommendations in relation to White women 8-10 so we conducted bivariate 
logistic regressions to examine sterilization recommendations by race of patient, using White women as the control 
group. Micronesian women (60%) received more frequent sterilization recommendations compared to White women 
(27%; B = 1.39, SE = .66, Wald χ2(1) = 4.39, P = .04). In addition, Chinese (38%), Filipina (41%), and Hawaiian 
(39%) women, were more likely to receive sterilization recommendations as compared to White women, although 
these comparisons failed to reach conventional levels of statistical significance (P > 0.34).  
 
Student Characteristics and Contraceptive Recommendations 
 For the 23-year-old patient, contraceptive recommendations did not differ by the participant’s race (χ2(12) = 
10.75, P = .55; Table 3). However, recommendations were related to students’ previous clinical experience with 
contraception (Spearman correlation r = .22, P = .029) such that students who reported having more experience with 
contraception in a clinical setting were more likely to recommend increasingly effective methods (e.g., IUDs and 
implants).  
For the 36-year-old patient, contraceptive recommendations did not differ by the student’s race (χ2(15) = 
15.44, P = .42; Table 4). Recommendations were related to students’ previous clinical experience with contraception 
(spearman correlation r = .28, P = .005) such that students who reported having more experience with contraception 
in a clinical setting were more likely to recommend increasingly effective methods (e.g., IUDs, implants and 
sterilization). When examining recommendations for sterilization specifically, responses did not differ by participant 
8 
 
race (χ2(3) = 2.02, P = .57), but were related to experience (spearman correlation r = .24, P = .018) such that  
students who reported having more experience in a clinical setting were more likely to recommend sterilization. 
 
Discussion 
We found statistically significant differences in the frequency of recommendations for sterilization when 
identical case descriptions of a 36-year old woman requesting birth control were presented with variations in only 
the patient’s name. This study adds to the literature exploring the role of a patient’s race/ethnicity in 
recommendations for contraception. Although this topic has been examined in other published studies describing 
differences in contraceptive use in women of different races, the mechanisms underlying these differences are 
unclear.8, 10 Social psychological research suggests that subconscious biases held toward certain groups of people is 
widespread, even among those who self-identify as non-discriminatory.23, 24 Providers’ personally held beliefs, in 
addition to their previous experience, could influence their interactions with patients and clinical recommendations, 
thereby contributing to continuing health disparities.4, 5 Though we are unable to draw conclusions on the biases of 
health care providers early in their training, our findings suggest that women of different races may receive different 
contraceptive recommendations. 
That IUDs were most frequently recommended, regardless of the race/ethnicity of the patient, may reflect 
the increased emphasis for recommending long-acting reversible contraception (LARC) as a “top-tier” 
contraceptive.25, 26 Medical students may recognize both the high efficacy and reversibility of LARC, particularly in 
younger women when future fertility is likely to be desired. Although participants may have identified the IUD as a 
“top-tier” method, their recommendations were not solely based on contraceptive efficacy. Though DMPA has a 
lower failure rate than oral contraceptive pills, pills were more commonly recommended than DMPA. We did not 
collect data on why participants recommended pills more frequently than DMPA in this survey. However, their 
recommendations parallel current contraceptive use in the United States where 4.5% of reproductive age women 
who use contraception select DMPA compared to 25.9% who select the oral contraceptive pill.27  Additionally, 
participants may have perceived fewer barriers to the continuation of oral contraceptive pills which are often 
prescribed and refilled at 12 month intervals in contrast to DMPA which requires a return visit to a health center 
every 3 months for continuation.  
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While IUDs were commonly recommended for the older patients, particularly for White women, in line 
with other studies examining differences in contraceptive recommendations in racial minorities in the continental 
US, a trend toward Micronesian women receiving more frequent recommendations for sterilization was noted.12, 14, 
18, 28 Though we did not elicit reasons for different contraceptive recommendations and therefore cannot draw 
conclusions on the etiology of different recommendations, biases of health care providers towards Micronesians has 
been described.22, 29  Micronesian migrants frequently cite limited economic resources in their western Pacific island 
of origin as a reason for moving to the US and are often categorized as “low income” once they arrive to the US.30 
These results are consistent with several previous studies demonstrating that, in comparison to White women, Black 
women and Hispanic women more frequently report that they were encouraged by providers to limit their family 
size.8, 10, 17, 31, 32 Whereas society may encourage white, middle-class women to become mothers, low-income, 
minority women may be discouraged from childbearing both through media messages and public policy.8, 17  For 
example, “welfare family caps”, policies which deny or reduce cash aid for babies born to women already receiving 
financial assistance exist in many states.17   When comparing hospital admission rates across a range of diseases (e.g. 
cardiac, infections, cancer, endocrine, or substance abuse), in comparison to other racial/ethnic groups in Hawaiʻi, 
Micronesians tend to be younger and manifest more severe symptoms.22 When socioeconomic standing is 
compounded with limited English proficiency, cultural differences in communication styles and limited skills in 
navigating a complex health care system, health care providers may classify Micronesian patients as “difficult” with 
a higher risk of non-compliance and loss to follow up.30  This may have been why a method like sterilization, which 
requires no ongoing compliance or return visits on the part of the user to remain highly effective, was recommended 
more frequently for Micronesian patients.   
Potential limitations should be noted. Prototypical names are frequently used to depict individuals from 
different racial groups within social psychological research.33 The names used in this study were carefully selected 
to be representative of the targeted racial groups. It is still possible, however, that individual participants may not 
have associated names with the targeted race. Additionally, we did not state if the patient’s insurance covered all 
forms of contraception in the case studies, which may have limited the recommendations made by some of the 
students. Students may have recommended methods like the IUD not because of its characteristics but because 
patients could continue to use the method regardless of insurance status, access to health care providers or their 
ability to pay for ongoing use which could be a problem with methods like condoms, DMPA or the oral 
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contraceptive pill.  Our measure of clinical experience was subjective; whether participants used similar criteria to 
gauge previous experience is unclear. 
Our findings suggest that the push by national organizations to increase the use of LARC has been 
successful.  Participants were overall more likely to recommend IUDs, as compared to all other methods, to the 23-
year-old patient and equally likely to recommend IUDs and sterilization to the 36-year-old patient; making IUDs the 
most recommended method across the entire study.  The literature on health care disparities frequently attempts to 
address whether better or poorer health is due to individuals of different races being clinically different or being 
treated differently by clinicians.  Our results draw attention to potential of racial/ethnic differences in patient 
counseling and the need for awareness of potential differences when promoting sterilization. Future research must 
investigate ways to promote patient-centered, unbiased care in order to help reduce current health disparities.  
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Figure 1. Contraception recommendations for the 23-year-old by patient race 
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Figure 2. Contraception recommendations for the 36-year-old by patient race 
 
*DMPA = Depot Medroxprogestereone Acetate 
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Table 1. Patient Case Studies 
 
Younger Patient 
Name is a 23 year old woman who comes in to your office requesting a method of 
birth control. She has no previous pregnancies.  Name became sexually active at 
age 18.  She does not have a history of sexually transmitted infections.  Testing 
for gonorrhea and chlamydia three months ago was negative. Name’s blood 
pressure today is normal. Name states that she does not want to become pregnant 
for at least a couple of years.    
Older Patient 
Name is a 36 year old woman who comes in to your office requesting a method of 
birth control. She has two children. Name became sexually active at age 18 and is 
currently in a monogamous relationship.  She does not have a history of sexually 
transmitted infections.  Name’s blood pressure today is normal.  Name states that 
she does not want to become pregnant again. 
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Table 2. Names for each Racial/Ethnic Group 
 
Race/Ethnicity Name 
White Claire Patterson, Heather Anderson 
Chinese Ying Cheung,  Mei Wong 
Filipina Rhea Mae Aquino, Mariel Bautista 
Hawaiian Keikilani Kapahu, Kailani Mahelona 
Micronesian Jayleen Morelik, Merly Sigrah 
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Table 3. Contraception recommendations for the 23-year-old by participant demographics 
 
 Type of contraception 
 Condom Pill Depot 
Medroxypro- 
gesterone acetate 
Etonogestrel 
implants 
IUD* Female 
Sterilization 
Participant Race n (%) n (%) n (%) n (%) n (%) n (%) 
East/Southeast Asian 
(n = 60) 
4 (7) 14 (23) 5 (8) 9 (15) 28 (47) 0 
Multiracial (n = 17) 1 (6) 5 (29) 0 2 (12) 9 (53) 0 
White (n = 13) 2 (15) 2 (15) 0 3 (23) 6 (46) 0 
Hawaiian (n = 4) 0 3 (75) 0 0 1 (25) 0 
Other/Missing (n = 9) 1 (11) 0 0 3 (33) 5 (56) 0 
Participant Experience with Birth Control in a Clinical Setting 
None (n = 20) 4 (20) 6 (30) 3 (15) 2 (10) 5 (25) 0 
Not Very Much  
(n = 17) 
2 (12) 4 (24) 0 1 (6) 10 (59) 0 
A Little (n = 21) 1 (5) 5 (24) 1 (5) 4 (19) 10 (48) 0 
Some (n = 30) 1 (3) 7 (23) 1 (3) 6 (20) 15 (5) 0 
Very Much (n = 9) 0 2 (22) 0 2 (22) 5 (56) 0 
Substantial (n = 2) 0 0 0 1 (50) 1 (50) 0 
Missing (n = 4) 0 0 0 1 (25) 3 (75) 0 
 
*IUD = intrauterine device. Note. Regardless of Participant Race students more likely to recommend IUDs followed 
by the contraception pill and Etonogestrel implant (χ2 (4) = 59.86, P < .001). Students who reported having more 
experience with contraception in a clinical setting were likely to recommend increasingly effective methods 
(Spearman correlation r = .22, P = .029).  
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Table 4. Contraception recommendations for the 36-year-old by participant demographics 
 
 Type of contraception 
 Condom Pill Depot 
Medroxypro-
gesterone Acetate 
Etonogestrel 
implants 
IUD* Female 
Sterilization 
Participant Race n (%) n (%) n (%) n (%) n (%) n (%) 
East/Southeast Asian 
(n = 60) 
0 5 (8) 1 (2) 2 (3) 23 (38) 29 (48) 
Multiracial (n = 17) 0 1 (6) 0 0 9 (53) 7 (41) 
White (n = 13) 1 (8) 1 (8) 0 1 (8) 6 (46) 4 (31) 
Hawaiian (n = 4) 0 1 (25) 0 1 (25) 1 (25) 1 (25) 
Other/Missing (n = 9) 0 1 (11) 1 (11) 1 (11) 5 (56) 1 (11) 
Participant Experience with Birth Control in a Clinical Setting 
None (n = 20) 1 (5) 3 (15) 1 (5) 1 (5) 9 (45) 5 (25) 
Not Very Much  
(n = 17) 
0 2 (12) 0 0 10 (59) 5 (29) 
A Little (n = 21) 0 3 (14) 1 (5) 2 (9) 5 (24) 10 (48) 
Some (n = 30) 0 0 0 3 (10) 11 (37) 16 (53) 
Very Much (n = 9) 0 0 0 0 5 (56) 4 (44) 
Substantial (n = 2) 0 0 0 0 0 2 (100) 
Missing (n = 4) 0 0 0 0 4 (100) 0 
 
*IUD = intrauterine device. Note. Regardless of Participant Race students more likely to recommend IUDs and 
female sterilization (χ2 (5) = 118.65, P < .001). Students who reported having more experience with contraception in 
a clinical setting were likely to recommend increasingly effective methods (Spearman correlation r = .28, P = .006), 
and female sterilization (Spearman correlation r = .24, P = .018). 
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